KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Consolidated Net Income (2019 - 2026)

GoodRx Holdings' Consolidated Net Income history spans 7 years, with the latest figure at $5.4 million for Q4 2025.

  • On a quarterly basis, Consolidated Net Income fell 19.51% to $5.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $30.4 million, a 85.72% increase, with the full-year FY2025 number at $30.4 million, up 85.72% from a year prior.
  • Consolidated Net Income hit $5.4 million in Q4 2025 for GoodRx Holdings, up from $1.1 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for GDRX hit a ceiling of $58.8 million in Q2 2023 and a floor of -$41.7 million in Q3 2022.
  • Historically, Consolidated Net Income has averaged -$1.0 million across 5 years, with a median of $1.4 million in 2021.
  • The widest YoY moves for Consolidated Net Income: up 4254.49% in 2023, down 1211.82% in 2023.
  • Tracing GDRX's Consolidated Net Income over 5 years: stood at -$39.9 million in 2021, then soared by 95.06% to -$2.0 million in 2022, then crashed by 1211.82% to -$25.9 million in 2023, then skyrocketed by 126.05% to $6.7 million in 2024, then fell by 19.51% to $5.4 million in 2025.
  • Business Quant data shows Consolidated Net Income for GDRX at $5.4 million in Q4 2025, $1.1 million in Q3 2025, and $12.8 million in Q2 2025.